Carbamazepine and Eye haemorrhage - a phase IV clinical study of FDA data


Eye haemorrhage is found among people who take Carbamazepine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Carbamazepine and have Eye haemorrhage. It is created by eHealthMe based on reports of 38,703 people who have side effects when taking Carbamazepine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 02, 2022

38,703 people reported to have side effects when taking Carbamazepine.
Among them, 14 people (0.04%) have Eye haemorrhage.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 39,566 Carbamazepine users for its effectiveness, alternative drugs and more.

What is Eye haemorrhage?

Eye haemorrhage (bleeding in the eye) is found to be associated with 1,353 drugs and 875 conditions by eHealthMe.

Number of Carbamazepine and Eye haemorrhage reports submitted per year:

Could Carbamazepine cause Eye haemorrhage?

Time on Carbamazepine when people have Eye haemorrhage *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Eye haemorrhage when taking Carbamazepine *:

  • female: 53.85 %
  • male: 46.15 %

Age of people who have Eye haemorrhage when taking Carbamazepine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.69 %
  • 20-29: 15.38 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 38.46 %
  • 60+: 38.46 %

Common drugs people take besides Carbamazepine *:

  1. Actemra: 3 people, 21.43%
  2. Regular Insulin: 3 people, 21.43%
  3. Nph Insulin: 3 people, 21.43%
  4. Eylea: 2 people, 14.29%
  5. Simvastatin: 2 people, 14.29%
  6. Albuterol: 2 people, 14.29%
  7. Omeprazole: 2 people, 14.29%
  8. Lucentis: 2 people, 14.29%
  9. Aspirin: 2 people, 14.29%
  10. Avastin: 2 people, 14.29%

Common side effects people have besides Eye haemorrhage *:

  1. Visual Impairment: 5 people, 35.71%
  2. Blindness Unilateral: 5 people, 35.71%
  3. Joint Pain: 4 people, 28.57%
  4. Blindness: 4 people, 28.57%
  5. Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 4 people, 28.57%
  6. High Blood Pressure: 3 people, 21.43%
  7. Nausea And Vomiting: 3 people, 21.43%
  8. Retinal Disorder (disease of retina): 3 people, 21.43%
  9. Cataract (clouding of the lens inside the eye): 3 people, 21.43%
  10. Drug Ineffective: 3 people, 21.43%

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 21.43%
  2. Diabetes: 3 people, 21.43%
  3. Pain: 2 people, 14.29%
  4. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 14.29%
  5. Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 2 people, 14.29%
  6. Asthma: 2 people, 14.29%
  7. Osteoporosis (bones weak and more likely to break): 1 person, 7.14%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
  9. Insomnia (sleeplessness): 1 person, 7.14%
  10. High Blood Pressure: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Carbamazepine and have Eye haemorrhage?

Check whether Eye haemorrhage is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Eye haemorrhage and when was it recovered:

Expand to all the drugs that have ingredients of carbamazepine:

Alternative drugs to, pros and cons of Carbamazepine:

Common Carbamazepine side effects:

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Eye haemorrhage treatments and more:

COVID vaccines that are related to Eye haemorrhage:

Common drugs associated with Eye haemorrhage:

All the drugs that are associated with Eye haemorrhage:

Common conditions associated with Eye haemorrhage:

All the conditions that are associated with Eye haemorrhage:

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Carbamazepine) and Carbamazepine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: